Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma

Author:

Lévi-Strauss Thomas1ORCID,Tortorici Bettina2,Lopez Olivier2,Viau Philippe3,Ouizeman Dann J.1,Schall Baptiste4,Adhoute Xavier5,Humbert Olivier67,Chevallier Patrick2,Gual Philippe8,Fillatre Lionel4ORCID,Anty Rodolphe18ORCID

Affiliation:

1. Hepatology Unit, University Hospital of Nice, 151 Route de Saint Antoine de Ginestière, 06200 Nice, France

2. Department of Diagnosis and Interventional Imaging, University Hospital of Nice, 151 Route de Saint Antoine de Ginestière, 06200 Nice, France

3. Department of Nuclear Medicine, University Hospital of Nice, 151 Route de Saint Antoine de Ginestière, 06200 Nice, France

4. CN3S, I3S, Université Côte d’Azur, 06000 Nice, France

5. Saint Joseph Hospital, 26 Bd de Louvain, 13008 Marseille, France

6. Centre Antoine-Lacassagne, Department of Nuclear Medicine, 33 Av. de Valombrose, 06100 Nice, France

7. TIRO-UMR E 4320, Université Côte d’Azur, 06000 Nice, France

8. INSERM, U1065, C3M, Université Côte d’Azur, 06000 Nice, France

Abstract

Radiomics is a discipline that involves studying medical images through their digital data. Using “artificial intelligence” algorithms, radiomics utilizes quantitative and high-throughput analysis of an image’s textural richness to obtain relevant information for clinicians, from diagnosis assistance to therapeutic guidance. Exploitation of these data could allow for a more detailed characterization of each phenotype, for each patient, making radiomics a new biomarker of interest, highly promising in the era of precision medicine. Moreover, radiomics is non-invasive, cost-effective, and easily reproducible in time. In the field of oncology, it performs an analysis of the entire tumor, which is impossible with a single biopsy but is essential for understanding the tumor’s heterogeneity and is known to be closely related to prognosis. However, current results are sometimes less accurate than expected and often require the addition of non-radiomics data to create a performing model. To highlight the strengths and weaknesses of this new technology, we take the example of hepatocellular carcinoma and show how radiomics could facilitate its diagnosis in difficult cases, predict certain histological features, and estimate treatment response, whether medical or surgical.

Funder

“Investments for the Future” LABEX SIGNALIFE project

UCAJEDI project

National Research Agency

Association Française pour l’Etude du Foie

Centre Hospitalier Universitaire de Nice

Université Côte d’Azur

INSERM

Société Nationale Française de Gastro-Entérologie

Publisher

MDPI AG

Subject

Clinical Biochemistry

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3